Comparison of mass spectrometry and radioimmunoassay to measure medroxyprogesterone acetate in patients with endometrial cancer.
Kärkkäinen, J
Comparison of mass spectrometry and radioimmunoassay to measure medroxyprogesterone acetate in patients with endometrial cancer. [electronic resource] - European journal of cancer (Oxford, England : 1990) 1990 - 975-7 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0959-8049
10.1016/0277-5379(90)90624-3 doi
Aged
Antineoplastic Agents--blood
Female
Gas Chromatography-Mass Spectrometry
Humans
Medroxyprogesterone--analogs & derivatives
Medroxyprogesterone Acetate
Middle Aged
Radioimmunoassay
Time Factors
Uterine Neoplasms--blood
Comparison of mass spectrometry and radioimmunoassay to measure medroxyprogesterone acetate in patients with endometrial cancer. [electronic resource] - European journal of cancer (Oxford, England : 1990) 1990 - 975-7 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0959-8049
10.1016/0277-5379(90)90624-3 doi
Aged
Antineoplastic Agents--blood
Female
Gas Chromatography-Mass Spectrometry
Humans
Medroxyprogesterone--analogs & derivatives
Medroxyprogesterone Acetate
Middle Aged
Radioimmunoassay
Time Factors
Uterine Neoplasms--blood